J9260 Injection methotrexate sodium 50mg
Also known as: methotrexate, Trexall
Intravenous injection of methotrexate sodium, a folic acid antagonist antimetabolite chemotherapy, dosed at 50 milligrams.
In Plain Language
DNA-inhibiting cancer drug; immunosuppressive chemotherapy
Clinical Context
Used for acute leukemias, lymphomas, and various solid tumors including breast cancer and osteosarcoma.
RVU Information
CPT J9260 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9260?
CPT J9260 (Injection methotrexate sodium 50mg) is a J Codes (Drugs) code. Intravenous injection of methotrexate sodium, a folic acid antagonist antimetabolite chemotherapy, dosed at 50 milligrams.
How is J9260 administered?
CPT J9260 is administered by a healthcare provider, typically via injection or infusion. Used for acute leukemias, lymphomas, and various solid tumors including breast cancer and osteosarcoma. It is used by Oncology, Medical Oncology.
When is CPT J9260 used?
Used for acute leukemias, lymphomas, and various solid tumors including breast cancer and osteosarcoma.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.